Active ingredients: Cefotaxime
Cefotaxime Sodium for Injection.
Powder for solution for injection or infusion.
Vials containing a white to slightly yellow powder, which when dissolved in Water for Injections forms a straw coloured solution. The intensity of the colour of the solution may vary but this does not indicate differences in potency or safety.
| Cefotaxime (as cefotaxime sodium) per vial | Diluent to be added | Final concentration of solution |
|---|---|---|
| 500 mg | 2 ml | 500 mg/2.2 ml |
| 1 g | 4 ml | 1 g/4.4 ml |
A quantity of cefotaxime sodium equivalent to 1 g cefotaxime contains approximately 50 mg (2.2 mmol) of sodium.
For excipients see 6.1.
Cefotaxime exerts its action by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thereby inhibiting cell wall synthesis.
None.
500 mg and 1 g presentations in 10 ml glass vials closed with rubber stoppers and sealed with aluminium caps.
Packaged singly or in cartons of 10, 25 or 50.
Villerton Invest SA, Rue Edward Steichen 14, 2540 Luxembourg
PL 24780/0008
10/10/2011